Idarucizumab may reverse dabigatran anticoagulation in intracranial hemorrhage

LOS ANGELES – It only took a few minutes for idarucizumab to normalize blood-clotting parameters in 18 patients with dabigatran-associated intracranial hemorrhages, according to interim results from...
Source: Family Practice News - Category: Primary Care Source Type: news